In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Human papillomavirus (HPV) Tests are primarily used to screen for cervical cancer and/or identify women who may be at increased risk of cervical cancer. GlobalData uses proprietary data and analytics to provide a comprehensive report on the human papilloma virus market in New Zealand. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the human papilloma virus market in New Zealand was Abbott Laboratories followed by F. Hoffmann-La Roche, Hologic and Qiagen.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
The HPV test determines whether a woman's cervical cells are infected with a high-risk type of human papillomavirus (hrHPV). HPV testing includes the sub-segments Human Papilloma Virus (HPV) Nucleic Acid Amplification Tests (NAATs) and Other Human Papilloma Virus (HPV) test kits.
The human papilloma virus market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size human papilloma virus in New Zealand, buy the report here.